canrenoic acid has been researched along with Disease Models, Animal in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Behar-Cohen, F; Bertaim, T; Dahmana, N; Gabriel, D; Gurny, R; Kalia, YN; Kaltsatos, V; Mugnier, T | 1 |
| Eguchi, A; Hayashi, SM; Inohana, M; Kawashima, M; Koyanagi, M; Maronpot, RR; Mizukami, S; Murayama, H; Nagahara, R; Nakamura, M; Shibutani, M; Yoshida, T | 1 |
| Aractingi, S; Behar-Cohen, F; Farman, N; Jaisser, F; Nguyen, VT; Palacios-Ramirez, R; Sbeih, M | 1 |
| Bos, R; Lechat, P; Médiani, O; Mougenot, N; Vanhoutte, PM | 1 |
| Araki, T; Ino, H; Mabuchi, H; Shimizu, M; Takeda, R; Yoshio, H | 1 |
5 other study(ies) available for canrenoic acid and Disease Models, Animal
| Article | Year |
|---|---|
Topical Administration of Spironolactone-Loaded Nanomicelles Prevents Glucocorticoid-Induced Delayed Corneal Wound Healing in Rabbits.
Topics: Administration, Ophthalmic; Animals; Canrenoic Acid; Cornea; Corneal Injuries; Disease Models, Animal; Glucocorticoids; Humans; Male; Micelles; Mineralocorticoid Receptor Antagonists; Nanoparticles; Polyesters; Polyethylene Glycols; Rabbits; Spironolactone; Tissue Distribution; Treatment Outcome; Wound Healing | 2018 |
Differential impacts of mineralocorticoid receptor antagonist potassium canrenoate on liver and renal changes in high fat diet-mediated early hepatocarcinogenesis model rats.
Topics: Animals; Antioxidants; Canrenoic Acid; Catalase; Diet, High-Fat; Disease Models, Animal; Gene Expression; Glutathione S-Transferase pi; Kidney; Liver; Liver Neoplasms; Mineralocorticoid Receptor Antagonists; NADPH Oxidases; Organ Specificity; Quercetin; Receptors, Mineralocorticoid; Signal Transduction | 2018 |
Cutaneous Wound Healing in Diabetic Mice Is Improved by Topical Mineralocorticoid Receptor Blockade.
Topics: Animals; Canrenoic Acid; Cell Differentiation; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Disease Models, Animal; Female; Humans; Lipocalin-2; Macrophages; Mice; Mice, Knockout; Mineralocorticoid Receptor Antagonists; Receptors, Mineralocorticoid; RNA, Small Interfering; Skin; Skin Ulcer; Wound Healing | 2020 |
Potassium canrenoate, an aldosterone receptor antagonist, reduces isoprenaline-induced cardiac fibrosis in the rat.
Topics: Animals; Blood Pressure; Canrenoic Acid; Cardiomyopathies; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrosis; Heart Rate; Isoproterenol; Male; Mineralocorticoid Receptor Antagonists; Neurotransmitter Agents; Rats; Rats, Wistar | 2004 |
Effects of angiotensin-converting enzyme inhibitor and aldosterone antagonist on myocardial collagen in cardiomyopathic hamsters.
Topics: Aging; Animals; Body Weight; Canrenoic Acid; Captopril; Cardiomyopathies; Collagen; Cricetinae; Disease Models, Animal; Heart; Hydroxyproline; Male; Organ Size | 1995 |